Protagonist Therapeutics Prepares for Follow-On Offering as Key Peptide Drug Nears FDA Milestone
Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a clinical-stage biotech company specializing in peptide-based therapeutics, is reportedly planning a follow-on public offering to fund late-stage clinical...
Ramaco Resources Eyes Secondary Offering Amid Strong Demand for U.S. Metallurgical Coal
Ramaco Resources, Inc. (NASDAQ: METC), a leading U.S. producer of metallurgical coal, is reportedly exploring a secondary equity offering to capitalize on the recent...
One and One Green Tech Prices Downsized U.S. IPO at $5 Midpoint
Philippine Recycling Firm Adapts to Market Volatility
Philippines-based recycling and waste management company One and One Green Tech has priced its downsized U.S. IPO at...
Evommune Files for $100 Million IPO to Advance Chronic Inflammatory Disease Therapies
Biotech Bets on IPO Window Reopening
Evommune, a clinical-stage biotechnology company developing treatments for chronic inflammatory diseases, has filed for a $100 million IPO as...
Xsolla SPAC 1 Files for $250 Million IPO Amid Growing Gaming Industry Consolidation
A New SPAC Enters the Market
SPAC Xsolla SPAC 1, formed by executives from global video game commerce company Xsolla, has filed for a $250...
